Pozen (POZN) -24.7% premarket after the biotech company discloses the FDA requested additional...

|By:, SA News Editor

Pozen (POZN) -24.7% premarket after the biotech company discloses the FDA requested additional data for its PA32540 fixed-dose "safer aspirin" product which may delay submission of its new drug application.